Synthetic chemerin-derived peptides that resemble the C-terminal amino acids of this adipokine reduce inflammation and enhance phagocytosis [41,90], and they may be used as therapeutic agents for the treatment of metabolic diseases and possibly further chronic inflammatory disorders. The gene discussed is RARRES2; the disease is Other metabolic disease.